PD Dr. Jörg Distler



Organisationseinheit


Heisenberg-Professur für Molekulare Mechanismen der Organfibrose


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 18 Go to next page Go to last page

Liang, R.f., Kagwiria, R., Zehender, A., Dees, C., Bergmann, C., Ramming, A.,... Distler, J. (2019). Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215066
Renoux, F., Stellato, M., Vogetseder, A., Huang, R., Subramaniam, A., Blyszczuk, P.,... Distler, O. (2019). FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1065-1065). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Wollin, L., Distler, J., Redente, E., Riches, D., Stowasser, S., & Schlenker-Herceg, R. (2019). FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES. In RESPIROLOGY (pp. 171-171). HOBOKEN: WILEY.
Harrach, S., Barz, V., Pap, T., Pavenstaedt, H., Schlatter, E., Edemir, B.,... Bertrand, J. (2019). Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts. Journal of Investigative Dermatology, 139(2), 439-447. https://dx.doi.org/10.1016/j.jid.2018.08.021
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Sobanski, V., Giovannelli, J., Allanore, Y., Riemekasten, G., Airo, P., Vettori, S.,... Poindron, V. (2019). Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. Arthritis and Rheumatology. https://dx.doi.org/10.1002/art.40906
Distler, J. (2019). POTENTIAL CELLULAR AND MOLECULAR TARGETS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 32-33). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M.,... Hunzelmann, N. (2019). Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. Dallas, TX, US: NEW YORK: AMER THORACIC SOC.
Pachera, E., Assassi, S., Salazar, G., Frank-Bertoncelj, M., Distler, J., Kania, G., & Distler, O. (2019). PROFIBROTIC LNCRNA H19X: UNRAVELLING THE EFFECTS ON CHROMATIN REMODELING IN SYSTEMIC SCLEROSIS FIBROBLASTS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 167-168). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Fischer, A., & Distler, J. (2019). Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clinical Rheumatology. https://dx.doi.org/10.1007/s10067-019-04720-0

Zuletzt aktualisiert 2017-08-11 um 01:00